FBInvestor
Stocks / Grace Therapeutics Inc
Institutional Ownership

Grace Therapeutics Inc

CUSIP 00439U104COMGRCEQ1 2026

13D / 13G Filings
8
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
13.0%
Max % of class reported
Institutional Holders
32
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

8 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Adar1 Capital Management, LLC13G/A13.0%1.65MSEC
2Feb 13, 2026Nantahala Capital Management, LLC13G/A10.0%1.59MSEC
3Jan 28, 2026Orin Hirschman13G/A5.9%907.22BSEC
4Aug 14, 2025Nantahala Capital Management, LLC13G/A10.0%1.40MSEC
5May 15, 2025Nantahala Capital Management, LLC13G10.0%1.39MSEC
6May 8, 2025Hirschman Orin13G/A9.9%1.32TSEC
7Jan 29, 2025Orin Hirschman13G/A5.1%521.1KSEC
8Nov 14, 2024Bank Of America Corp /De/13G/A4.9%494.7KSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →